Company Filing History:
1 out of 2,405 
1 out of 10 Years Active: 2022
Title: The Innovator Profile: Jeffrey W. Shubert
Introduction: Jeffrey W. Shubert, a talented inventor based in North Wales, PA, holds one patent in the field of neurological and psychiatric disorders. His groundbreaking work focuses on heteroarylpiperidine ether compounds as allosteric modulators of the M4 muscarinic acetylcholine receptor, with potential implications for the treatment and prevention of various diseases.
Latest Patents: Jeffrey W. Shubert's notable patent is for the development of heteroaryl piperidine ether compounds as allosteric modulators of the M4 muscarinic acetylcholine receptor. This innovation opens up new possibilities for addressing neurological and psychiatric disorders, showcasing his expertise and dedication to advancing medical treatments.
Career Highlights: During his career, Jeffrey W. Shubert has made significant contributions to the field of pharmaceuticals. He has worked with esteemed companies such as Merck Sharp & Dohme Corporation and MSD R&D (China) Co., Ltd., where his innovative ideas and research have made a lasting impact on the industry.
Collaborations: Jeffrey W. Shubert has collaborated with accomplished professionals in his field, including coworkers like Jianming Bao and Ronald Dale Ferguson II. Through these collaborations, he has been able to exchange ideas, conduct research, and bring his inventive concepts to fruition.
Conclusion: In conclusion, Jeffrey W. Shubert stands out as a remarkable inventor with a passion for developing novel compounds with significant therapeutic potential. His work in the field of neurological and psychiatric disorders is paving the way for innovative treatments, and his collaborations and career achievements further underscore his dedication to driving advancements in medicine.